Vaginal Microbiota

2

Review clinical trials related to Vaginal Microbiota. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Pesticides and Infertility: Oxidative Stress Via Circulating Cell-free DNA and Gut/Genital Microbiome Signatures in Women With Endometriosis

This project PestiEndoMicro aims to provide an innovative approach, studying endometriosis under the genital and gut microbiota scope. To realize this project, the investigators are planning to dose cfDNA to assess the oxidative stress caused by endometriosis and study its epigenetics. At the same time, the investigators will take a pragmatic approach by assessing pesticide exposure in these patients and estimate the correlation between gut or genital dysbiosis and chemical agent exposure. Also, the investigators will take the initiative to use classic culture, qPCR techniques, and NGS to establish signatures in vaginal, endometrial and gut microbiota in patients with endometriosis. With these approaches, the goal is to gain more knowledge about endometriosis and optimize early diagnosis by establishing a signature in the genital and gut microbiota, but also by dosing the cfDNA. By doing so the investigators could open new opportunities to develop new therapeutic strategies for endometriosis.

Participants needed: 160
Trial details
Age: 18-43Biological sex: FemaleType: InterventionalSponsor: Centre Hospitalier Universitaire, AmiensUpdated: May 15, 2026Locations: 1
Eligibility criteria

All women aged 18 to 43, with confirmed endometriosis and endometriosis grade 3... [+4]

All women aged 44 and over. [+7]

Status: Recruiting

Gut and Vaginal Microbiota Profile Study for HIV Women

Women Living with HIV Infection (WLHIV)are intended to acquire HPV infection which usually contributes to variable cervical lesions. we hypothesize that vaginal microbiota imbalance may make WLHIV prone to HPV infection,thereafter results in severe cervical lesion.

Participants needed: 400
Trial details
Age: 14+Biological sex: FemaleType: ObservationalSponsor: Peking Union Medical College HospitalUpdated: Dec 9, 2025Locations: 1Duration: 3 Years
Eligibility criteria

HIV women (including pregnant); [+1]

virgin or maiden